Low fouling strategies for electrochemical biosensors targeting disease biomarkers

2019 ◽  
Vol 11 (6) ◽  
pp. 702-711 ◽  
Author(s):  
Nianzu Liu ◽  
Zhenying Xu ◽  
Aoife Morrin ◽  
Xiliang Luo

This minireview summarizes recent trends in the development of low fouling electrochemical biosensors based on different antifouling materials.

2018 ◽  
Vol 116 ◽  
pp. 89-99 ◽  
Author(s):  
Murugesan Balamurugan ◽  
Paulraj Santharaman ◽  
Thangamuthu Madasamy ◽  
Seenivasan Rajesh ◽  
Niroj Kumar Sethy ◽  
...  

2021 ◽  
Vol 11 (4) ◽  
pp. 309-334
Author(s):  
Jae Hyun Kim ◽  
Young Joon Suh ◽  
Dongsung Park ◽  
Hyoju Yim ◽  
Hongrae Kim ◽  
...  

F1000Research ◽  
2017 ◽  
Vol 6 ◽  
pp. 670 ◽  
Author(s):  
Roberto I. Lopes ◽  
Armando Lorenzo

The objective of this article is to present an overview of recent trends in the management of Wilms’ tumor. With improved survival rates in the past few decades, critical long-term adverse therapy effects (such as renal insufficiency, secondary malignancies, and heart failure) and prevention measures (i.e. nephron-sparing surgery and minimizing the use of radiotherapy) have gained worldwide attention. Specific disease biomarkers that could help stratify high-risk from low-risk patients, and therefore fine-tune management, are in great demand. Ultimately, we aim to enhance clinical outcomes and maintain or improve current survival rates while avoiding undesirable treatment side effects and minimizing the exposure and intensity of chemotherapy and radiotherapy.


2004 ◽  
Vol 76 (4) ◽  
pp. 861-878 ◽  
Author(s):  
Silvana Andreescu ◽  
O. A. Sadik

Biochemical sensors have emerged as a dynamic technique for qualitative and quantitative analysis of different analytes in clinical diagnosis, environmental monitoring, and food and process control. The need for a low-cost, reliable, ultra-sensitive, and rapid sensor continues to grow as the complexity of application areas increases. New biosensing techniques are emerging due to the need for shorter sample preparation protocols. Such novel biosensor designs make field and bed-site clinical testing simpler with substantial decrease in costs per sample throughputs. In this paper, we will review the recent trends and challenges in clinical and environmental biosensors. The review will focus on immunological, nucleic acid, and cell-based clinical and biological sensors. Special emphasis will be placed on the approaches used for immobilization or biological reagents and low-cost electrochemical biosensors. The promising biosensors for rapid diagnosis of cancer or HIV are also discussed.


Sign in / Sign up

Export Citation Format

Share Document